Coral Genomics

Acquired

New clinical tests for managing autoimmune treatments.

San Francisco, United States · Founded 2018 · $2.1M raised

Employees
1–10
Founded
2018
Business Model
B2B
Total Funding
$2.1M

About

Coral integrates molecular, functional, and clinical factors to create new clinical laboratory tests that predict optimal treatments for autoimmune diseases. We have also identified a unique subpopulation of patients who do not respond to current therapies and are working towards addressing this unmet medical need.

Summary

Coral Genomics is a Genomics company based in San Francisco, United States, founded in 2018. It has raised $2.1M in total.

Funding History

No funding data available yet.

Know something? Help us improve our data.

Similar Companies